IPO registrations (S-1, F-1) · Registrants
Prometheus Biosciences, Inc.
- SEC CIK
- 1718852 · filings on EDGAR ↗
- Former names
- Precision IBD, Inc. (2017–2019)
- Registration
- Form S-1, first filed 2021-02-19, last 2021-03-11; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2021-03-12; declared effective 2021-03-11
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3050 SCIENCE PARK ROAD, San Diego, CA 92121
- EIN
- 81-4282653
- EDGAR entity type
- operating
- Insiders and CEO pay
- Prometheus Biosciences, Inc. on the corporate pages
Offering terms
- Proposed price range
- $18.00–$19.00 per share (S-1/A filed 2021-03-11)
- Final price
- $19.00 per share, within the range (424B4 filed 2021-03-12, an initial public offering)
- Shares sold
- 10,000,000
- Gross proceeds
- $190,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol RXDX
- Lead underwriters
- Leerink Partners; Credit Suisse
- Syndicate
- Stifel; Guggenheim Securities; Accounts receivable — (1,086); Current assets of discontinued operations (32,602)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: PROMETHEUS BIOSCIENCES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: PROMETHEUS BIOSCIENCES, INC. EXACT (EIN (EXACT))
- Form D issuer: Prometheus Biosciences, Inc. EXACT (CIK (EXACT))
- SEC filer: Prometheus Biosciences, Inc. EXACT (CIK (EXACT))
- Person page: Judith L Swain Md Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-19 | S-1 | S-1 (registration) | Prometheus Biosciences, Inc. | 0001193125-21-049126 ↗ |
| 2021-03-08 | S-1/A | S-1/A (amendment) | Prometheus Biosciences, Inc. | 0001193125-21-072143 ↗ |
| 2021-03-11 | S-1/A | S-1/A (amendment) | Prometheus Biosciences, Inc. | 0001193125-21-076931 ↗ |
| 2021-03-11 | S-1MEF | S-1MEF (added securities) | Prometheus Biosciences, Inc. | 0001193125-21-078278 ↗ |
| 2021-03-11 | EFFECT | EFFECT (declared effective) | Prometheus Biosciences, Inc. | 9999999995-21-000917 ↗ |
| 2021-03-12 | 424B4 | 424B4 (final prospectus) | Prometheus Biosciences, Inc. | 0001193125-21-079877 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-11 | S-1/A | registration statement | $18.00–$19.00 | 9,000,000 | - | Nasdaq RXDX | 6 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 2, cover names 4 | document ↗ | |
| 2021-03-12 | 424B4 | final prospectus | $19.00 | 10,000,000 | $190,000,000 | Nasdaq RXDX | 6 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| 72 Investment Holdings, LLC | Other; TenPercentOwner | 2 | 2021 | ||
| Adams Helen C. | Director | 6 | 2021–2023 | ||
| Andrews Timothy K. | Officer | General Counsel | 2 | 2021 | |
| CEDARS SINAI MEDICAL CENTER | TenPercentOwner | 2 | 2021 | ||
| Chen Bihua | DirectorOther; Director,TenPercentOwner | 3 | 2021 | ||
| COHEN STEVEN A/SAC CAPITAL MGMT LP | Other; TenPercentOwner | 2 | 2021 | ||
| Cormorant Asset Management, LP | Other; TenPercentOwner | 3 | 2021 | ||
| Cormorant Global Healthcare Master Fund, LP | Other; TenPercentOwner | 3 | 2021 | ||
| Cormorant Private Healthcare Fund III LP | Other; TenPercentOwner | 3 | 2021 | ||
| Differentiated Ventures Investments, LLC | Other; TenPercentOwner | 2 | 2021 | ||
| EDELMAN JOSEPH | TenPercentOwner | 2 | 2021 | ||
| Hendrix Martin | Director | 5 | 2021–2023 | ||
| Laur James | Director | 5 | 2021–2023 | ||
| Luo Allison | Officer | Chief Medical Officer | 3 | 2021 | |
| Marshall Keith W | Officer | Chief Financial Officer | 11 | 2021–2023 | |
| McKenna Mark C. | Director,Officer | Chairman, President and CEO; Chairman, President & CEO; President and CEO | 11 | 2021–2023 | |
| PAPA JOSEPH C | Director | 7 | 2021–2023 | ||
| PERCEPTIVE ADVISORS LLC | TenPercentOwner | 2 | 2021 | ||
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | TenPercentOwner | 2 | 2021 | ||
| Point72 Biotech Private Investments, LLC | Other; TenPercentOwner | 2 | 2021 | ||
| RTW INVESTMENTS, LP | TenPercentOwner | 2 | 2021 | ||
| Stenhouse Mark | Officer | Chief Operating Officer | 7 | 2021–2023 | |
| Swain Judith L | Director | 4 | 2021–2023 | person page Fuzzy | |
| Szela Mary T | Director | 5 | 2021–2023 | ||
| WONG RODERICK | TenPercentOwner | 2 | 2021 | ||
| Yamada Tadataka | DirectorOther | 2 | 2021 | ||
| NESTLE SA | TenPercentOwner | 1 | 2021 | ||
| Societe des Produits Nestle S.A. | TenPercentOwner | 1 | 2021 | ||
| Hassan Fred | Director | 6 | 2021–2023 | ||
| Cedars Sinai Intellectual Property Co | TenPercentOwner | 3 | 2021–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-11-12 | Prometheus Biosciences, Inc. | Biotechnology | $130,000,000 | $50,000,000 | 15 | 1 |
| 2019-07-15 | Prometheus Biosciences, Inc. | Biotechnology | $60,000,000 | $48,063,500 | 11 | 2 |
| 2018-11-28 | Precision IBD, Inc. | Biotechnology | $20,000,000 | $10,086,407 | 22 | 1 |
| 2017-10-10 | Precision IBD, Inc. | Biotechnology | $10,000,000 | $3,689,600 | 22 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | PROMETHEUS BIOSCIENCES, INC. | CA | State business registries | name and state |
| Form D issuer | Prometheus Biosciences, Inc. | CA | Form D private offerings | CIK (EXACT) |
| IPO registrant | IMMUSOL INC | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 3050 SCIENCE PARK RD 92121 (FUZZY: a shared address, not proof of a shared organization) |
| Patent assignee | PROMETHEUS BIOSCIENCES, INC. | CA | Patents (USPTO) | name and state |
| SEC filer | Prometheus Biosciences, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | PROMETHEUS BIOSCIENCES, INC. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | PROMETHEUS BIOSCIENCES, INC. | EIN (EXACT) | ||
| Person page | Judith L Swain Md | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- RIGEL PHARMACEUTICALS INC CA
- Diadexus, Inc. CA
- CymaBay Therapeutics, Inc. CA
- CRESCENDO PHARMACEUTICALS CORP CA
- SPIROS DEVELOPMENT CORP II INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health